Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Total 13F shares
-
7,155,750
-
Share change
-
+596,246
-
Total reported value
-
$1,763,174,202
-
Price per share
-
$246.54
-
Number of holders
-
166
-
Value change
-
+$148,477,786
-
Number of buys
-
88
-
Number of sells
-
57
Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q4 2025
As of 31 Dec 2025,
Krystal Biotech, Inc. - COMMON STOCK (KRYS) was held by
166 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,155,750 shares.
The largest 10 holders included
VANGUARD GROUP INC, Capital World Investors, GEODE CAPITAL MANAGEMENT, LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, NORGES BANK, PRINCIPAL FINANCIAL GROUP INC, UBS Group AG, Pictet Asset Management Holding SA, and Bank of New York Mellon Corp.
This page lists
166
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.